硬脂酰辅酶 A 去饱和酶 (SCD) 是膜流动性的关键调节剂,周转迅速,是内质网 (ER) 短寿命蛋白质选择性降解的模型。SCD 是一种限速脂肪生成酶,在催化单不饱和脂肪酸(主要是油酸和棕榈油酸)合成中起着不可或缺的作用。两者都是生物膜的主要组成部分。小鼠和人类中存在多种 SCD 同工型,即分别为 SCD-1 至 SCD-4 和 SCD-1 和 SCD-5。
SCD 的过度表达是显而易见的,并且与糖尿病和非酒精性脂肪肝等代谢疾病有关。SCD 还刺激典型 Wnt 通路和 YAP 激活,以支持干细胞和肿瘤发生。SCD 促进癌症中的代谢重编程,这至少部分是通过 MUFA 调节 AKT、AMPK 和 NF-kB 介导的。从生物学角度来看,SCD1 的过度表达会导致许多代谢紊乱,包括肥胖、胰岛素抵抗、高血压和高甘油三酯血症等。SCD1 是治疗肥胖、糖尿病和其他代谢疾病的药理学靶点。
Stearoyl-CoA desaturase (SCD) is a key regulator of membrane fluidity, turns over rapidly, and represents a model for selective degradation of short-lived proteins of the endoplasmic reticulum (ER). SCD is a rate-limiting lipogenic enzyme that plays an integral role in catalyzing the synthesis of monounsaturated fatty acids, chiefly oleate and palmitoleate. Both contribute a major part of the biological membrane. Numerous SCD isoforms exist in mouse and humans, i.e., SCD-1 to SCD-4 and SCD-1 and SCD-5, respectively.
Overexpression of SCD is evident and implicated in metabolic diseases such as diabetes and non-alcoholic fatty liver disease. SCD also stimulates canonical Wnt pathway and YAP activation in support of stemness and tumorigenesis. SCD facilitates metabolic reprogramming in cancer which is mediated, at least in part, by regulation of AKT, AMPK, and NF-kB via MUFAs. From the biological viewpoint, hyperexpression of SCD1 causes many metabolic disorders including obesity, insulin resistance, hypertension, and hypertriglyceridemia, etc. SCD1 is a pharmacological target in the treatment of obesity, diabetes and other metabolic diseases.
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号